The study also confirmed that AOD9604 works by inhibiting fat synthesis in liver and fat cells, providing additional mechanistic insight into how the peptide promotes metabolic health
Over July 2324, 2026, an FDA advisory committee recommended six of the seven peptides it reviewed including BPC-157, TB-500, and KPV be added back to the list of substances licensed pharmacies may compound, voting against the advice of the FDAs own scientific staff and rejecting only emideltide
Get In Touch With Us Schedule Your Free Consultation Take Your First Step Today Let our team of Medical Professionals help you achieve your body goals
Safety should never be compromised
The hypothesis stated that an increase in fatty acid oxidation in muscle and fat results in higher acetyl CoA in mitochondria leading to inactivation of two rate-limiting enzymes of glycolysis (i.e., phosphofructokinase (PFK) and pyruvate dehydrogenase (PDH) complex)